Oxidative stress in adolescents with overweight/obesity
Oxidative stress in obesity
Abstract
Aim: The pathophysiological mechanism underlying obesity and related diseases is still incompletely understood. A small number of studies used sophisticated statistical techniques, such as principal component analysis (PCA), to examine the relationship between oxidative stress, cardiometabolic biomarkers, and obesity in adolescent population. Hence, we aimed to explore such a relationship.
Methods: A total of 68 adolescents (i.e., 34 were overweight/obese and 34 were sex- and age-matched normal-weight controls) were included in the study. Total oxidant status (TOS) and total antioxidant status (TAS) were measured, whereas their ratios were calculated, i.e., pro-oxidant score [(TOS/TAS)*100] and antioxidant score (TAS/TOS). PCA was applied for reducing the number of determined data by grouping them into factors.
Results: A significantly higher concentration of TAS, TOS, and their pro-oxidant ratio (TOS/TAS)*100, while the antioxidant score of TAS/TOS was significantly lower in overweight/obese adolescents compared to normal-weight peers. TOS was the most significant predictor of obesity status (P=0.001). PCA extracted 3 factors related to obesity status: Factor 1 (gender, creatinine, uric acid, total bilirubin, TAS, waist circumference, and urea), Factor 2 (ALT and AST), and Factor 3 (age, glucose, total protein, and TOS). Among them, Factor 2 (P=0.003) and Factor 3 (P=0.003) were independently associated with obesity.
Conclusion: The present study provides evidence of disrupted redox homeostasis in adolescents with obesity. Obesity is tightly connected with increased oxidative stress and a cluster of metabolic abnormalities. It is important to recognize risk factors in a timely manner and develop a strategy to fight obesity and associated diseases.
Copyright (c) 2025 Marija Bozovic, Barbara Ostanek, Jelena Kotur-Stevuljevic, Janja Marc, Filiz Mercantepe, Aleksandra Klisic
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.